SC 13G/A | 2024-02-09 | Forsakringsaktiebolaget Avanza Pension | China SXT Pharmaceuticals, Inc. | 13,437 | 238.0% | EDGAR |
SC 13G | 2024-02-09 | Forsakringsaktiebolaget Avanza Pension | China SXT Pharmaceuticals, Inc. | 28,680 | 507.0% | EDGAR |
SC 13G/A | 2023-03-29 | Streeterville Capital LLC | China SXT Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
SC 13G | 2023-03-29 | Streeterville Capital LLC | China SXT Pharmaceuticals, Inc. | 1,043,580 | 10.0% | EDGAR |
SC 13G/A | 2023-02-13 | Lind Global Fund II LP | China SXT Pharmaceuticals, Inc. | 0 | - | EDGAR |
SC 13D/A | 2023-01-30 | Zhou Albert Feng | China SXT Pharmaceuticals, Inc. | 1,732,048 | 21.5% | EDGAR |
SC 13G | 2022-08-25 | Streeterville Capital LLC | China SXT Pharmaceuticals, Inc. | 202,936 | 10.0% | EDGAR |
SC 13G | 2022-01-21 | Lind Global Fund II LP | China SXT Pharmaceuticals, Inc. | 2,575,000 | - | EDGAR |
SC 13G/A | 2021-02-16 | Ayrton Capital LLC | China SXT Pharmaceuticals, Inc. | 298,330 | 0.4% | EDGAR |
SC 13G/A | 2021-02-11 | Hudson Bay Capital Management LP | China SXT Pharmaceuticals, Inc. | 298,329 | 0.5% | EDGAR |
SC 13G/A | 2020-02-14 | Ayrton Capital LLC | China SXT Pharmaceuticals, Inc. | 2,667,999 | 10.0% | EDGAR |
SC 13G | 2020-02-07 | Hudson Bay Capital Management LP | China SXT Pharmaceuticals, Inc. | 2,742,139 | 10.0% | EDGAR |
SC 13G | 2019-05-08 | Ayrton Capital LLC | China SXT Pharmaceuticals, Inc. | 2,000,000 | 7.5% | EDGAR |
SC 13D | 2019-02-15 | Zhou Albert Feng | China SXT Pharmaceuticals, Inc. | 8,500,000 | 37.7% | EDGAR |